Paradigm Biopharmaceuticals's total assets for Q2 2026 were AU$23.15M, a decrease of -5.77% from the previous quarter. PBIGF total liabilities were AU$17.16M for the fiscal quarter, a 406.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.